Kamil Ali-Jackson - 16 Dec 2021 Form 3 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)

Role
Director
Signature
/s/ Dolly Vance (Attorney-in-Fact)
Issuer symbol
RIGL
Transactions as of
16 Dec 2021
Net transactions value
$0
Form type
3
Filing time
17 Dec 2021, 15:20:10 UTC
Previous filing
17 Jun 2021
Next filing
05 Jan 2022

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney